NAP

Ref. 3D-PP44309

Informations sur le produit

• Nom: NAP
• Synonymes: H-NAPVSIPQ-OH

Description

Peptide NAP is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using NAP include the following: Neuroprotective peptide NAPVSIPQ antagonizes ethanol inhibition of L1 adhesion by promoting the dissociation of L1 and Ankyrin-G X Dou , JY Lee, ME Charness - Biological psychiatry, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006322319316592 A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha SM Fleming , CK Mulligan, F Richter, F Mortazavi - Molecular and Cellular , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1044743110002745 VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects S Sragovich, N Amram, A Yeheskel - Frontiers in Cellular , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fncel.2019.00589/full The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities S Oz , Y Ivashko-Pachima, I Gozes - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0051458 NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death RR Leker , A Teichner, N Grigoriadis, H Ovadia - Stroke, 2002 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/01.STR.0000014207.05597.D7 The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide O Ashur-Fabian , Y Segal-Ruder, E Skutelsky - Peptides, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978103002729 Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain NK Sharma , NK Sethy , RN Meena, G Ilavazhagan - Peptides, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978111001215 Is NAP an additional neuroprotector in Alzheimer's disease? MH Yang, YL Chen, CY Lu, WC Tsai, YC Tyan - and Genomic Medicine, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2214024713000622 Reduction of aluminum ion neurotoxicity through a small peptide application-NAP treatment of Alzheimer's disease MH Yang, SC Chen, YF Lin, YC Lee, MY Huang - Journal of Food and , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1021949819300109 Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity MF Wilkemeyer, S Chen, CE Menkari - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1331636100 Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL M Holtser-Cochav, I Divinski, I Gozes - Journal of molecular neuroscience, 2006 - Springerhttps://link.springer.com/article/10.1385/JMN:28:3:303 Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide M Bassan, R Zamostiano, A Davidson - Journal of , 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1471-4159.1999.0721283.x A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice L Beni-Adani , I Gozes , Y Cohen , Y Assaf - of Pharmacology and , 2001 - ASPEThttps://jpet.aspetjournals.org/content/296/1/57.short A novel peptide prevents death in enriched neuronal cultures I Zemlyak, S Furman, DE Brenneman, I Gozes - Regulatory peptides, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0167011500001981 Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides I Nakase, H Akita, K Kogure, A Graslund - Accounts of chemical , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ar200256e NAP alpha-aminoisobutyric acid (IsoNAP) I Gozes , Y Schirer, A Idan-Feldman, M David - Journal of Molecular , 2014 - Springerhttps://link.springer.com/article/10.1007/s12031-013-0103-8 D-SAL and NAP: two peptides sharing a SIP domain I Gozes , S Sragovich, Y Schirer - Journal of Molecular , 2016 - Springerhttps://link.springer.com/article/10.1007/s12031-015-0701-8 A novel VIP responsive gene: activity dependent neuroprotective protein I Gozes , R Zamostiano, A Pinhasov - Annals of the New , 2000 - Wiley Online Libraryhttps://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.2000.tb06957.x From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division I Gozes , I Divinsky, I Pilzer, M Fridkin - Journal of Molecular , 2003 - Springerhttps://link.springer.com/article/10.1385/JMN:20:3:315 NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42) I Gozes , I Divinski, I Piltzer - BMC neuroscience, 2008 - Springerhttps://link.springer.com/article/10.1186/1471-2202-9-S3-S3 NAP: Research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP) I Gozes , BH Morimoto , J Tiong, A Fox - CNS drug , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2005.tb00053.x Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) counteracts UV-B radiation-induced ROS formation in corneal epithelium G Maugeri , AG D'Amico, S Giunta, C Giallongo - Antioxidants, 2022 - mdpi.comhttps://www.mdpi.com/2076-3921/11/1/128 NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function FJ Quintana , R Zaltzman - Annals of the New , 2006 - Wiley Online Libraryhttps://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1196/annals.1317.069 A novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities D Blat, L Weiner, MBH Youdim - Journal of medicinal , 2008 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm070800l The interaction of possible anti-AD ASA-NAP peptide conjugate with tubulin: A theoretical and experimental insight CS Mocanu, G Drochioiu - International Journal of Peptide Research and , 2021 - Springerhttps://link.springer.com/article/10.1007/s10989-021-10267-z FTIR and MS evidence for heavy metal binding to anti-amyloidal NAP-like peptides AV Lupaescu , M Jureschi, CI Ciobanu , L Ion - Journal of Peptide , 2019 - Springerhttps://link.springer.com/article/10.1007/s10989-018-9672-2 Direct evidence for binding of aluminum to NAP anti-amyloid peptide and its analogs AV Lupaescu , I Humelnicu , BA Petre - Journal of Mass , 2020 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/1469066719877714 Zinc binding to NAP-type neuroprotective peptides: nuclear magnetic resonance studies and molecular modeling AV Lupaescu , CS Mocanu, G Drochioiu , CI Ciobanu - Pharmaceuticals, 2021 - mdpi.comhttps://www.mdpi.com/1424-8247/14/10/1011 Design and synthesis of new anti-amyloid NAP-based/like peptides AV Lupaescu , CI Ciobanu , I Humelnicu , BA Petre - Rev. Roum , 2019 - revroum.lew.rohttps://revroum.lew.ro/wp-content/uploads/2019/06/Art%2010.pdf

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 824.94 g/mol
• Formule: C₃₆H₆₀N₁₀O₁₂